论文部分内容阅读
目的:探讨血清AFU检测在肝癌中的应用价值。方法:采用回顾性分析法,选取我院2014年2月-2017年2月期间50例健康体检者和125例肝病科患者,空腹静脉血检测甲胎蛋白(AFP)和血清α-L-岩藻糖苷酶(AFU)浓度。结果:对照组与其他各组AFU、AFP阳性率比较有明显的差异性,P<0.05,有统计学意义;AFU诊断肝细胞癌敏感性优于AFP,P<0.05,有统计学意义。结论:肝癌患者血清AFU活性明显高于正常人,用于早期肝癌诊断中敏感性较高,AFP特异性比较高,二者联合能有效提高早期肝癌诊断率。
Objective: To investigate the value of serum AFU detection in liver cancer. Methods: A retrospective analysis method was used to select fasting venous blood for the detection of alpha-fetoprotein (AFP) and serum alpha-L-rock in 50 healthy subjects and 125 patients with hepatopathy from February 2014 to February 2017 in our hospital. Glucosidase (AFU) concentration. Results: The positive rates of AFU and AFP in the control group were significantly different from those in other groups (P <0.05, statistically significant). The sensitivity of AFU in diagnosing hepatocellular carcinoma was better than that of AFP, P <0.05, which was statistically significant. Conclusion: The serum level of AFU in patients with hepatocellular carcinoma is significantly higher than that in normal people. It is more sensitive in diagnosing early hepatocellular carcinoma and higher in AFP specificity. The combination of the two can effectively improve the diagnostic rate of early hepatocellular carcinoma.